Loading company details...
Latest Form 4 (Nov 13, 2026): Frederick G. Vogt (Interim CEO & General Counsel): Exercise/Conversion of 200,000 shares, $1.51M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Frederick G. Vogt, Interim CEO & General Counsel | Exercise/Conversion | 200,000 | $1.51M |
| Nov 12, 2026 | Daniel Gordon Kirby, Chief Commercial Officer | Exercise/Conversion | 10,000 | n/a |
| Nov 10, 2026 | Corleen M. Roche, Chief Financial Officer | Exercise/Conversion | 12,500 | n/a |
| Oct 2, 2026 | Noah Berkowitz, Chief Medical Officer | Grant/Award | 135,000 | n/a |
| Sep 10, 2026 | Frederick G. Vogt, Interim CEO & General Counsel | Exercise/Conversion | 15,626 | n/a |
| Sep 10, 2026 | Igor Bilinsky, Chief Operating Officer | Exercise/Conversion | 7,813 | n/a |
| Sep 10, 2026 | Raj K. Puri, Chief Regulatory Officer | Exercise/Conversion | 9,766 | n/a |
| Sep 3, 2026 | Frederick G. Vogt, Interim CEO & General Counsel | Exercise/Conversion | 41,669 | n/a |
| Sep 3, 2026 | Raj K. Puri, Chief Regulatory Officer | Exercise/Conversion | 5,470 | n/a |
| Sep 3, 2026 | Igor Bilinsky, Chief Operating Officer | Exercise/Conversion | 8,789 | n/a |